344 related articles for article (PubMed ID: 35784527)
21. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
22. Prolactin as an autocrine/paracrine factor in breast tissue.
Clevenger CV; Plank TL
J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
[TBL] [Abstract][Full Text] [Related]
23. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
24. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
25. Prolactin and breast cancer risk.
Tworoger SS; Hankinson SE
Cancer Lett; 2006 Nov; 243(2):160-9. PubMed ID: 16530327
[TBL] [Abstract][Full Text] [Related]
26. Interplay between progesterone and prolactin in mammary development and implications for breast cancer.
Lee HJ; Ormandy CJ
Mol Cell Endocrinol; 2012 Jun; 357(1-2):101-7. PubMed ID: 21945475
[TBL] [Abstract][Full Text] [Related]
27. Prolactin involvement in breast cancer.
Vonderhaar BK
Endocr Relat Cancer; 1999 Sep; 6(3):389-404. PubMed ID: 10516853
[TBL] [Abstract][Full Text] [Related]
28. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Schyve PM; Smithline F; Meltzer HY
Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
[TBL] [Abstract][Full Text] [Related]
29. Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis.
Karayazi Atıcı Ö; Govindrajan N; Lopetegui-González I; Shemanko CS
Semin Cell Dev Biol; 2021 Jun; 114():159-170. PubMed ID: 33109441
[TBL] [Abstract][Full Text] [Related]
30. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
32. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.
Arendt LM; Schuler LA
Am J Pathol; 2008 Jan; 172(1):194-202. PubMed ID: 18156207
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
34. Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer.
Ali S; Hamam D; Liu X; Lebrun JJ
Front Endocrinol (Lausanne); 2022; 13():993570. PubMed ID: 36157462
[TBL] [Abstract][Full Text] [Related]
35. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.
Gutzman JH; Rugowski DE; Schroeder MD; Watters JJ; Schuler LA
Mol Endocrinol; 2004 Dec; 18(12):3064-75. PubMed ID: 15319452
[TBL] [Abstract][Full Text] [Related]
36. Prolactin: the new biology of an old hormone.
Goffin V; Binart N; Touraine P; Kelly PA
Annu Rev Physiol; 2002; 64():47-67. PubMed ID: 11826263
[TBL] [Abstract][Full Text] [Related]
37. New concepts in prolactin biology.
Bernichtein S; Touraine P; Goffin V
J Endocrinol; 2010 Jul; 206(1):1-11. PubMed ID: 20371569
[TBL] [Abstract][Full Text] [Related]
38. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
39. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
40. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]